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ABSTRACT We have performed molecular dynamics simulations of multiple copies of the lung-surfactant peptide SP-B1-25 in
a palmitic acid (PA) monolayer. SP-B1-25 is a shorter version of lung-surfactant protein B, an important component of lung
surfactant. Up to 30 ns simulations of 20 wt % SP-B1-25 in the PA monolayers were performed with different surface areas of PA,
extents of PA ionization, and various initial conﬁgurations of the peptides. Starting with initial peptide orientation perpendicular
to the monolayer, the predicted ﬁnal tilt angles average 54; 62 with respect to the monolayer normal, similar to those
measured experimentally by Lee et al. (Biophysical Journal. 2001. Synchrotron x-ray study of lung surfactant-speciﬁc protein
SP-B in lipid monolayers. 81:572–585). In their ﬁnal conformations, hydrogen-bond analysis and amino acid mutation studies
show that the peptides are anchored by hydrogen bond interactions between the cationic residues Arg-12 and Arg-17 and the
hydrogen bond acceptors of the ionized PA headgroup, and the tilt angle is affected by the interactions of Tyr-7 and Gln-19 with
the PA headgroup. Our work indicates that the factors controlling orientation of small peptides in lipid layers can now be
uncovered through molecular dynamics simulations.
INTRODUCTION
Lung surfactant (LS) is a mixture of lipids, fatty acids, and
proteins that lines the epithelial cells of mammalian lungs.
The main function of LS is to reduce the surface tension at
the air-liquid interface during breathing, which stabilizes the
interface against collapse (1–3). Dysfunction or absence of
LS can lead to respiratory distress syndrome (RDS), which is
a leading cause of premature infant death (4). RDS has been
clinically treated with a mixture of bovine natural surfactant
and synthetic lipids (5,6). Although animal surfactants can
be used as replacements for human LS, their supply is
limited (7). In addition, they can cause infection or immunol-
ogical response. The most appropriate method for avoiding
these problems is to use synthetic mimics of the natural
peptides (8). To help in the development of these, it is
important to understand the interactions between surfactant
proteins and lipids and how these affect interfacial properties
in lungs.
Although experimental methods such as NMR, neutron
scattering, and x-ray scattering provide vital information on
the ensemble-averaged peptide-lipid interactions, these ex-
periments are not always easy to interpret at the level of
individual molecules or speciﬁc interactions between pro-
teins and lipids. On the other hand, molecular-level phe-
nomena can be visualized by molecular dynamics (MD)
simulations, which offer insights into membrane structure
and dynamics, as well as interactions between peptides and
membranes, assuming that these simulations can be vali-
dated by successful comparisons to available experimental
results.
LS consists of 90% lipids such as dipalmitoylphosphati-
dylcholine (DPPC), unsaturated phosphatidylcholine (PC),
phosphatidylglycerol (PG), palmitic acid (PA), and 8–10%
surfactant-associated proteins such as surfactant proteins A,
B, C, and D (SP-A, SP-B, SP-C, and SP-D) (9). Phospho-
lipids are most responsible for the surface properties in the
lung. DPPC, which is a zwitterionic phospholipid, is the
major surfactant phospholipid and plays an important role in
reducing surface tension by packing tightly at the air-liquid
interface. However, the interfacial properties of the phos-
pholipids are critically modulated by surfactant-associated
proteins. In particular, it has been thought that SP-B and SP-
C, which are small and hydrophobic surfactant proteins,
signiﬁcantly contribute to surface activity by disrupting the
ordered bilayers, producing ﬂuid-like structures that can
spread along the air-water interface more rapidly (10–17). It
is believed that SP-B and SP-C promote selective retention
of DPPC and squeeze-out of non-DPPC lipids (such as PG)
during monolayer compression, thereby helping monolayers
to become enriched in DPPC. However, some recent studies
show that absorbed surfactant monolayers and their asso-
ciated reservoirs possess similar lipid compositions, suggest-
ing that the ability of LS monolayers to attain low surface
tension is not dependent on their enrichment in DPPC, thus
arguing against the classical model of selective DPPC inser-
tion and PG squeeze-out during surfactant monolayer forma-
tion (18,19). In addition, it has been recently demonstrated
that disorder in bilayers does not speed up the adsorption of
pulmonary surfactant, suggesting that SP-B and SP-C fa-
cilitate rapid adsorption of pulmonary surfactant through
a mechanism other than the disruption of bilayers (20). SP-B
also regulates the processing of SP-C, an LS peptide that
apparently plays an important role in formation of the
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surfactant reservoir and in the reinsertion of surfactant into
the collapsed phase to allow reexpansion during inhalation
(21,22). Although SP-B and SP-C directly affect the prop-
erties of the phospholipid monolayer, SP-A and SP-D, which
are larger, hydrophilic proteins, play minor roles in the
surface activity. SP-A- or SP-D-knockout mice do not show
signs of respiratory malfunction, whereas SP-B knockout
mice exhibit fatal respiratory dysfunction (23). Therefore,
understanding the interactions of lipids with SP-B will be
important in the development of synthetic LS peptides.
The protein SP-B is relatively small (17.4 kDa),
homodimeric, and hydrophobic. Each 79-residue polypep-
tide chain of SP-B contains three disulﬁde bridges, and the
dimer is formed by a disulﬁde bond linking the Cys-48
residues of the two subunits (24). It has been demonstrated
that a shorter version of the protein, SP-B1-25, which contains
25 amino acids and is not dimerized, has the same effects on
the surface properties of the lung as does the whole peptide,
including resistance to the inhibitory effect of plasma
constituents on surfactant activity and partial restoration of
lung compliance in two animal models, as well as good lipid
mixing and adsorption activities (25). The sequence of SP-
B1-25 is FPIPL PYCWL CRALI KRIQA MIPKG. Fig. 1
shows the hydrophobic, cationic, and other hydrophilic
regions of SP-B1-25. The ﬁrst eight residues are highly
hydrophobic and are hypothesized to facilitate insertion of
the peptide into the lipid monolayer. Residues 9–22 form an
amphipathic a-helix, and residues 23–25 form a coil. In
Langmuir trough experiments with monolayers of PA, both
SP-B and SP-B1-25 have been shown to inhibit the formation
of condensed phases, resulting in a new ﬂuid phase (27,28).
Although PA is a minor component of LS, PA has been
demonstrated to be necessary for the proper functioning of
both natural and synthetic LS replacement (29). In addition,
it was observed that the addition of SP-B1-25 increases the
collapse pressure of PA monolayers to that of DPPC
monolayers (;70 mN/m). This suggests that the electrostatic
interactions between the peptide and PA counteract the
driving force for the squeeze-out of the ﬂuidizing compo-
nents such as PG and PA from LS monolayers (30,31). The
importance of interactions between PA and SP-B1-25 has
stimulated diverse qualitative and quantitative measurements
of this system by ﬂuorescence microscopy, Brewster angle
microscopy, x-ray grazing-incidence diffraction, and reﬂec-
tivity (27,28,32).
MD simulations have shown that SP-B1-25 forms stronger
interactions with DPPG lipid monolayers, which are anionic
lipids, than with DPPC monolayers, which are zwitterionic
(33). Recently, simulations of the interactions between SP-
B1-25 and DPPC lipid monolayers showed that the polar and
cationic amino acids of the peptide form hydrogen bond
interactions with headgroups of lipids, suggesting that these
hydrogen bonds help determine the position and orientation
of the peptide on the interface (34). PA, when deprotonated,
has anionic headgroups, which also can form speciﬁc in-
teractions with the cationic amino acids of the peptides. More-
over, the headgroup of PA is much smaller than that of
DPPC or POPC, making these fatty acids more mobile than
two-tailed lipids and hence faster to equilibrate in computer
simulations. Furthermore, peptides in PA have much better
x-ray contrast than the same peptides in lipids, which allows
their orientation and insertion depth to be inferred experi-
mentally. Therefore, SP-B1-25 in a PA monolayer is an
excellent model for both experiments and simulations to
study the conformation and dynamics of LS components.
X-ray diffraction studies of monolayers show the pre-
ferred conformation and orientation of SP-B1-25 in the PA
monolayer, as well as the effect of SP-B1-25 on the properties
of the PA monolayer (32). Earlier 2.7 ns-long simulations of
SP-B1-25 in a PA monolayer by Freites et al. (35) indicate
that the electrostatic interactions between the cationic pep-
tide residues and the anionic lipid headgroups are prominent
and may help anchor the peptide to the monolayer. However,
those simulations were performed with initial conﬁgurations
of the peptide/PA monolayer that were chosen to be the same
as ﬁnal conﬁgurations found in the experiment. Thus, simu-
lations that explore different initial peptide orientations and
that are run much longer than 2.7 ns are needed to conﬁrm
and expand on the ﬁndings of this early study. In addition,
speciﬁc interactions between the peptides and PA should be
analyzed at the atomic scale. In this study, we perform 30 ns-
long MD simulations to investigate both these atomic-scale
interactions between SP-B1-25 and PA monolayers as well as
larger molecular-scale properties, such as peptide orientation
and depth of insertion. Using various initial conditions, we
study the effect of the peptide on the monolayer structure
and, conversely, the effect of the anionic PA on the confor-
mation and orientation of the peptide and compare our results
with experimental ﬁndings (32). We are particularly interested
FIGURE 1 Structure of SP-B1-25. The peptide is represented as a ribbon.
Red regions represent cationic amino acids, blue regions represent other
hydrophilic amino acids, and green regions represent hydrophobic ones. The
image was created by using visual molecular dynamics (26).
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in the effect that individual amino acid residues have on the
peptide conformation and on monolayer properties. These
results should help in the rational design of synthetic LS
peptides.
METHODS
All the simulations and analyses were performed using the GROMACS
simulation package with the GROMACS force ﬁeld (36,37). The united-
atom parameter set for lipids was downloaded from http://moose.bio.ucal-
gary.ca/Downloads and then used for the PA tail. For PA headgroup,
parameters for amino acids were used. The peptide structure and coordinates
were downloaded from the Protein Data Bank (PDB code: 1DFW) (38).
Hydrogen atoms of the PA headgroup and the peptide were ﬁxed by deﬁning
an additional bond of appropriate length between the hydrogen atom and the
linked atom, which allows the time step to be increased to 5 fs without
inﬂuencing thermodynamical and dynamical properties of the system (39).
The SPC water model was used for all simulations.
Monolayer conﬁguration and equilibration
The simulated system consists of two monolayers with 144 PA molecules in
each monolayer, ;6800 water molecules, and counterions to make the
system neutral. Several monolayers were constructed with different surface
areas, namely, 20 A˚2/PA, 24 A˚2/PA, and 28 A˚2/PA, as well as different
proportions of PA ionization, namely, 0%, 25%, 33%, 50%, and 100%.
Uniformity in positioning of the ionized and un-ionized PA molecules was
achieved by grouping together in the monolayer sets of four PA molecules
containing un-ionized and ionized PA in the ratios 4:0, 3:1, 2:2, and 0:4 to
make 0%-, 25%-, 50%-, and 100%-ionized PA monolayers. Nine PA
molecules were also grouped in the ratio 6:3 un-ionized/ionized PA to make
a 33%-ionized PA monolayer. For the monolayer with 24 A˚2/PA, those four
or nine PA molecules were replicated, respectively, 36 times or 16 times to
make a 144-PA monolayer with the size 5.879 nm 3 5.879 nm 3 2.2 nm.
After duplicating this 144-PA monolayer, the two monolayers were placed
face-to-face, parallel to the xy direction, and the distance between
headgroups of the two monolayers was set to 6 nm;;6800 water molecules
were placed between the hydrophilic faces of the monolayers in a box of size
5.879 nm 3 5.879 nm 3 6 nm. Na1 and Cl ions were added in positions
that minimize electrostatic energy. Enough ions were added both to
neutralize charges from the PA and peptide and to create a concentration of
150 mM NaCl. Periodic boundary conditions were applied in all three
directions. A region of vacuum with dimensions 5.879 nm3 5.879 nm3 5
nm was introduced above the tail region of the upper monolayer and below
the tail region of the lower monolayer to separate the tail regions of the two
monolayers from each other in the periodic box. For densities of 20 and 28
A˚2/PA, the same procedures were performed with different box dimensions.
Table 1 shows the parameter values chosen for each step of the simu-
lations. A cutoff was used for van der Waals interactions, and particle mesh
Ewald (PME) summation was used for electrostatic interactions (40). The
temperature was maintained at 298.15 K by applying a Berendsen thermostat
(41). AnNVT ensemble was used to ﬁx the surface areas of PA; therefore, the
pressure ﬂuctuated during the simulations. After energy minimization,
equilibration runs were performed for 10 ns during which no water or
counterions were observed to penetrate through the PA tails into the vacuum
region. The ﬁnal PA conﬁgurationswere analyzed for the puremonolayer and
then used as the starting states for inserting the peptide into the monolayer.
Peptide insertion and equilibration
Peptides were inserted into the equilibrated monolayers obtained from step
1, using methods similar to what we have reported earlier (34). Brieﬂy, a hole
for inserting peptides was made by following the well-established ‘‘hole’’
protocol (42). The ‘‘MSMS’’ program was used for scanning the surface of
peptides (43), and then a hole-making force was introduced perpendicularly
to the scanned surfaces of the peptide. The peptide was inserted into the
resulting hole, and then several steps of energy minimization were per-
formed with position restraints applied to the peptide. To attain the desired
concentration of peptides in the PA monolayer, namely, 20 wt % SP-B1-25,
three peptides were added to each monolayer, requiring prior removal of
nine PA molecules and the associated counterions for the charged PA
molecules. Removal of nine PA molecules per monolayer leads to an
increase in surface area per PA from 24 and 28 A˚2/PA to 25.6 and 29.9 A˚2/
PA, respectively. With the added peptides, counterions were added into the
water to neutralize the system. Thus, the ﬁnal system consists of 6 peptides,
270 PA molecules, ;6800 water molecules, and 62, 128, and 332 ions for
0%-, 25%-, and 100%-ionized PA monolayers, respectively. Then, the back-
bone atoms of the peptide were position restrained, and an equilibration run
of 0.5 ; 1 ns was performed under the conditions listed in Table 1 to allow
the PA molecules to equilibrate around each peptide. The ﬁnal conﬁguration
from this equilibration run was used as the starting condition for the pro-
duction runs. The peptides were inserted in several different initial conﬁgu-
rations, listed in Table 2 and Fig. 2, to test for equilibration of the system.
Production runs
MD simulations of SP-B1-25/PA monolayer systems prepared using the
above procedure were carried out with parameter values listed in Table 1.
Using the NVT ensemble, the surface area of PA was ﬁxed at 25.6 or 29.9
A˚2/PA, and the pressure was allowed to ﬂuctuate. As in the preparation
steps, the temperature was maintained at 298.15 K by applying a Berendsen
thermostat, a cutoff was used for van der Waals interactions, and PME
summation was used for the electrostatic interactions. The LINCS algorithm
was used to constrain the bond lengths (44). The simulations were performed
for 30 ns with a time step of 2.5 ; 5 fs. The coordinates were saved every
picosecond for analysis.
RESULTS AND DISCUSSION
Peptide-free simulations
Experimentally, monolayer electrostatics and ionic strength
of the buffer play an important role in determining the phase
behavior of the lipid monolayer. A certain proportion of
carboxyl groups in the headgroups of PA are ionized at pH
6.9 (the estimated pH of water containing 150 mM NaCl),
TABLE 1 Simulation parameters for each step; all simulations
were performed in the NVT ensemble
PA
equilibration
Peptide
insertion
Peptide-PA
equilibration
Production
run
Temperature (K) 298.15 298.15 298.15 298.15
VdW cutoff (nm) 1.2 1.2 1.2 1.2
Electrostatics PME PME PME PME
Length of the run
(ns)
10 0.01 0.5 ; 1 30
Position restraints - Carbon atoms
next to PA
headgroups
in the x, y
plane
Peptide
backbone
-
Position restraint
force (kJ/mol/nm2)
- 1000 1000 -
Hole-making force
(kJ/mol/nm)
- 100 - -
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which can affect the properties of the PA monolayer. The
extent of ionization of the PA monolayers at pH 6.9 (in saline
buffer at 0.15 M NaCl) has been shown by the Gouy-
Chapman theory to vary from 24% at 17 A˚2/PA (16C),
which is the area per PA at which collapse of the PA
monolayer occurs below the triple point, to 39% at 40 A˚2/
PA, which is the area per PA for the expanded-to-condensed
phase transition of the PA monolayer above the triple point
(28C) (28). Therefore, we have chosen a 25%-ionized PA
monolayer as a reference ionization condition to use in our
simulations. We have performed a series of 10 ns simulations
of pure monolayers containing 288 PA molecules, at densi-
ties of 20 A˚2/PA, 24 A˚2/PA, and 28 A˚2/PA, along with
;6800 water molecules and counterions.
Peptide simulations
We have performed MD simulations of 6 SP-B1-25 molecules
(3 per monolayer) and 270 PAmolecules (135 per monolayer)
with different initial conﬁgurations of the peptide, surface
areas of PA, and extent of PA ionization. Table 2 shows the
different initial conditions of all the simulations. The simula-
tions were performed for 30 ns at surface densities of 25.6 A˚2/
PA or 29.9 A˚2/PA in an NVT ensemble. Fig. 2 shows
snapshots from the beginning (top image) and end of all the
simulations (bottom image). Final conformations show that
the peptides become highly tilted and interact strongly with
PA molecules. The observed average tilt angles of the pep-
tides in each monolayer correspond reasonably closely to the
angles determined experimentally by Lee et al. (32). Although
the simulations were performed over a run time of 30 ns, the
average properties were analyzed only over the last 10 ns
when the system is in its most equilibrated state.
In Fig. 3, a–d, mass densities of the peptide and PA tail
and head regions are plotted for the pure PA monolayer and
the monolayer containing PA-SP-B1-25. In the presence of
the peptide, the PA tail and head regions become much
broader than in the pure PA monolayer. This occurs because
the strong interactions of PA molecules with the peptides can
pull PA molecules out of the monolayers. In Fig. 3, c and d,
the breadth of the PA head region matches that of the peptide
region, suggesting a strong interaction between the peptide
and the PA head region.
The effect of SP-B1-25 on ﬂuidization of the
PA monolayer
SP-B1-25 inhibits the formation of condensed phases in
monolayers of PA, resulting in a disordered, ﬂuid, mono-
layer phase (27,28). The PA tail conformational order can be
quantiﬁed by the order parameter Scc.
Scc ¼ 3
2
Æcos2 uZæ 1
2
where uZ is the angle that the vector connecting carbons Cn 
1 to Cn 1 1 makes with the z axis. The bracket indicates
averaging over time and over all molecules in the simulation.
Order parameters can vary between 1 (perfect orientation in
the interface normal direction) and 1/2 (perfect orientation
perpendicular to the normal) (45).
Fig. 4, a and b, shows the order parameters of the pure PA
monolayer with different extents of PA ionization and
surface areas. In Fig. 4 a, the order parameters of the PA tails
are almost identical for ionizations in the range 0% ; 50%,
showing that this level of ionization does not affect the
ordering of the monolayer. However, the order parameters of
100%-ionized PA are much reduced, showing that the 100%-
ionized PA monolayer is much more disordered. This occurs
because of interfacial ﬂuctuations, which are driven by
repulsive forces between negatively charged headgroups of
PA molecules. In Fig. 4 b, the monolayer at a surface density
TABLE 2 List of simulations; note that in SPB3, the ionized PA molecules are initially placed randomly within the monolayer
Area per PA
(A˚2/PA)
Extent of
ionization in
PA (%)
Distribution of
ionized PA
Numbers of peptides with tabulated
initial angle formed by helix
with monolayer normal
Total
simulation
time (ns)Name Ensemble 0 45 90
SPB1 NVT 25.6 0 Spatially regular 6 - - 30
SPB2 NVT 25.6 25 Spatially regular 6 - - 30
SPB2-MUT1* NVT 25.6 25 Spatially regular 6 - - 30
SPB2-MUT2* NVT 25.6 25 Spatially regular 6 - - 30
SPB2-MUT3* NVT 25.6 25 Spatially regular 6 - - 30
SPB3 NVT 25.6 25 Spatially random 6 - - 30
SPB4 NVT 25.6 25 Spatially regular 4 - 2 30
SPB5 NVT 25.6 25 Spatially regular - 6 - 30
SPB6 NVT 25.6 25 Spatially regular 2 - 4 30
SPB7 NVT 25.6 25 Spatially regular - - 6 30
SPB8 NPT 25.6 100 Spatially regular 6 - - 30
SPB9 NVT 29.9 25 Spatially regular 6 - - 30
*SPB2-MUT1, SPB2-MUT2, and SPB2-MUT3 are mutated peptides.
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of 28 A˚2/PA is more disordered than at 24 A˚2/PA, probably
because there is more space in the former for reorientation of
PA molecules. However, the monolayer at 20 A˚2/PA is more
disordered than that at 24 A˚2/PA, presumably because of
ﬂuctuations of the interface caused by the strong repulsive
force between the tightly packed PA molecules. In addition,
the ﬁfth carbon close to the headgroup is more disordered
than other carbons close to the headgroup. In Fig. 4 b, when
the surface area of PA is 28 A˚2/PA, the ﬁfth carbon is more
disordered, whereas when the surface area of PA is 20 A˚2/
PA, this disordering of the ﬁfth carbon rarely occurs. This
disordering of the ﬁfth carbon is robust at the higher surface
area, since we also found disorder of the ﬁfth carbon in
simulations of a monolayer of a shorter PA tail (10 carbons),
similar to the disorder of a normal PA tail. We also heated up
the PA system to 350 K and then cooled it down to 298 K,
and similar behavior of the ﬁfth carbon was found.
Experimental measurement of the order parameter of PA
would allow this predicted speciﬁc disordering to be con-
ﬁrmed, unless it is an artifact of the force ﬁelds. The pos-
sibility of such an artifact cannot be ruled out at this point
because force ﬁelds of lipids have been parameterized based
on bilayers, not monolayers.
We also calculated the order parameters of PA monolayers
in the presence of peptides. Each PA monolayer is divided
into two regions based on the distance from the peptide
molecules. If any part of a PA molecule is within 5 A˚ of the
surface of the peptide, it is considered to be ‘‘close’’ to the
FIGURE 2 Snapshots at the beginning (0 ns,
top image for each of parts a–i) and end (30 ns,
bottom image) of all the simulations. PA
molecules are positioned on the top and bottom
of the system. Three peptides for each mono-
layer are oriented perpendicularly or horizon-
tally with respect to the monolayer normal.
Water molecules between monolayers are
represented as blue dots. Vacuum is introduced
above the upper monolayer and beneath the
lower monolayer to avoid interactions between
monolayers across the periodic boundary
condition. One system contains six peptides,
270 PA molecules, and ;6800 water mole-
cules. All simulations were performed for 30 ns.
The ﬁnal conformations of the systems show
that peptides become more tilted and interact
more intimately with the monolayers as time
increases.
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peptide, whereas otherwise it is ‘‘far’’ from the peptide.
Using this criterion, each monolayer consists of 75; 80 PA
molecules close to each peptide and 55 ; 69 PA molecules
far from any of the peptides. Fig. 4, c and d, shows order
parameters of PA in the SPB2 system, which is 25%-ionized
with a density of 25.6 A˚2/PA. Notice that in the vicinity of
the peptides there is signiﬁcant disordering of PA relative to
pure PA monolayers, and that there is less disordering for
PA molecules far from the peptides. This disordering is
consistent with experimental observations, which show that
the insertion of the peptides disrupts and disorders the
membranes, causing the formation of a novel disordered
ﬂuid phase (27,28). In the experiments, the disordered phase
is in equilibrium with an ordered phase whose molecular
packing is not affected by the peptide (32), suggesting that
the peptide is only located in the disordered portion of the
monolayer. (In the simulations, the patch of monolayer is too
small to allow clear phase separation between disordered and
order surface phases.) Notice that in the simulations the PA
molecules far from the peptide, although less disordered than
those close to the peptide, are nevertheless more disordered
than those in the pure PA monolayer. This disordering
apparently occurs because PA molecules tend to condense
near the peptides to interact intimately with them, leading to
an increased surface area of the remaining PA molecules,
even those far from the peptide.
Secondary structures and orientation of
SP-B1-25 in the PA monolayer
SP-B1-25 consists of an a-helical structure, whose stability in
the PA layer and angle relative to the monolayer normal we
here investigate. The peptides in the monolayers at 25.6 A˚2/PA
are observed to have a stable a-helical structure extending
from the 8th residue, cysteine, to the 21st residue, methi-
onine. On the other hand, in the monolayers at 29.9 A˚2/PA
the a-helical structure only extends from the 10th residue,
leucine, to the 15th residue, isoleucine, showing that at this
lower packing density the a-helical structure is less stable.
The 16th residue, lysine, at 29.9 A˚2/PA is observed to form
only a coil. This result corresponds to simulations performed
by Freites et al., which show instability of the a-helical struc-
ture to formation of a more random conformation at around
the 16th or 17th residue (35). The a-helical structure in the
monolayer with a higher surface area is apparently less stable
because of the exposure of the peptide to more water mole-
cules. For the peptide in pure water, the a-helix is broken after
300 ps, apparently by the presence of the water molecules.
Lee et al. measured peptide orientation by constructing
a four-box model representing the electron densities of the
composite objects, peptide-water, peptide-PA head, peptide-
PA tail, and PA tail groups, derived from x-ray reﬂectivity
data (32). From this, they inferred that the average peptide
FIGURE 3 Mass density proﬁles of
(a) the lower layer and (b) the upper
layer of the pure PA monolayer, and (c)
the lower layer and (d) the upper layer
of the PA-SP-B1-25 monolayer.
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tilt angle was 56. In our simulations, we investigate the
conformations of the peptides by measuring directly the tilt
angle, which we deﬁne as the angle between the monolayer
normal and the a-helical axis of the peptide (Fig. 5 a), where
the a-helical axis is given by the 8th–21st residues of the
peptide. Speciﬁcally, to deﬁne this axis, the center of mass of
the aggregate of atoms consisting of the backbone atoms for
the 8th; 10th residues and two backbone atoms (N and Ca)
of the 11th residue is calculated. Likewise, the center of mass
of the backbone atoms of the 19th ; 21st residues and two
backbone atoms (Ca and C) of 18th residues is also cal-
culated, and the line connecting these two centers of mass is
used to measure the tilt angle.
Fig. 5, b and c, shows the time dependencies of the tilt
angles of six peptides over a period of 30 ns, in simulations
SPB2 and SPB4. Each peptide was initially positioned
perpendicularly or horizontally with respect to the mono-
layer normal as described in Fig. 2 and Table 2. In simu-
lations SPB2 and SPB3, all peptides started vertically (0).
Note that the tilt angles increase rapidly for 10 ns, and little
systematic change is observed after 20 ns. In Fig. 5 c, for
simulation SPB4, four peptides start vertically and two start
horizontally. Although the four initially vertical peptides
show drastic changes in orientation, similar to the peptides in
simulations SPB2 and SPB3, the orientations of the two
initially horizontal peptides do not show large changes and
merely ﬂuctuate around 90. This stability of the horizontal
peptides is apparently produced by the hydrogen bonds that
form between the peptides and the headgroups of the PA
molecules. Early formation of hydrogen bonds can prevent
the free movement of the peptides, which leads to restricted
conformational sampling (34). Lack of free movement of the
peptides shows the limitation of simulations over timescales
of tens of nanoseconds, which is too short to break hydrogen
bonds frequently enough to overcome local energy minima
and allow the peptide to sample thoroughly conﬁguration
space. This trend is also observed in simulations SPB5,
SPB6, and SPB7, showing that tilt angles merely ﬂuctuate
around 90, similar to the peptides that started horizontally in
simulation SPB4.
Fig. 5 d shows the instantaneous tilt angles averaged over
all six peptides from each monolayer system. Although tilt
angles of the individual peptides are observed to ﬂuctuate in
Fig. 5, b and c, the tilt angles averaged over six peptides have
smaller ﬂuctuations and yield nearly constant angles after 20 ns.
Therefore, the average tilt angles of the ﬁnal conformations
FIGURE 4 Order parameters of acyl chains of PA. The order parameters of pure PA monolayers were measured for (a) different extents of PA ionization at
a surface area of 24 A˚2/PA and (b) different surface areas of PA in a 25%-ionized PA monolayer. The order parameters of PA in SPB3, which initially had all
perpendicular peptides, were measured for (c) lower and (d) upper layers. Each monolayer of SPB3 is divided into two regions including an area far from the
SP-B1-25 and the remaining area close to the peptides.
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were analyzed between 20 ns and 30 ns in all simulations,
and the results were tabulated in Table 3. Although for each
simulation the peptide tilt angles span a broad range of
values, in simulations SPB2, SPB3, and SPB4, these average
peptide tilt angles are nearly the same, ranging only from 54
to 62. Those angles are similar to the experimental value of
56 obtained from the x-ray reﬂectivity experiments by Lee
et al. (32). On the other hand, simulation SPB5 has a ﬁnal
average tilt angle of 67, SPB6 has 78, and SPB7 has 91,
which are much higher than the other simulation results and
the experimental value. These higher average tilt angles
occur because of the limited conformational sampling by the
horizontally inserted peptides, as discussed in the analysis of
the tilt angles of individual peptides.
In addition to the direct measurement of the peptide tilt
angle, we calculated peptide orientation by constructing
a four-box model of computed electron densities, mimicking
the four-box model ﬁtted to experimental electron densities
by Lee et al. (32). The average tilt angles of the peptides
obtained from the four-box models ﬁtted to the simulated
FIGURE 5 Peptide tilt angle (a), computed by measuring the angle between a-helix of the peptide and the z axis, with 0 representing a vertical orientation
and 90 a horizontal one. Tilt angles of the individual peptides in (b) SPB2 and (c) SPB4. (d) Tilt angles averaged over all six peptides of each simulation as
a function of simulation time.
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electron density proﬁles are in the range 52–70, similar to
the range of angles obtained from the four-box model ﬁtted
to the experiments. For the simulations, where the peptide
was initially vertical the ﬁts to four-box models yielded
orientation angles of 52–55, much closer to those calculated
directly from the orientation of the a-helical region, which
were in the range 54–62. However, for initially horizontal
peptides, the directly calculated tilt angle was;90, whereas
that from the four-box model was ;70. These results indi-
cate that ﬁts to four-box models are not sensitive to orienta-
tion angles .;70 and that our simulation results, although
not completely converged, do yield orientation angles con-
sistent with experimental results, to within the accuracy of
the experiments.
In addition to the simulations of the PA monolayers with
20 wt % SP-B1-25, PA monolayers with 7 wt % SP-B1-25,
which corresponds to one peptide per monolayer, were also
simulated. Fig. 6 shows the tilt angles of the peptides in three
such simulations with different initial conﬁgurations. Tilt
angles change rapidly for the ﬁrst 5 ns and then become
stable after ;15 ns, which is similar to the behavior seen
in the 20 wt % SP-B1-25 systems. In Fig. 6 c, the peptides,
which were initially horizontal, stay horizontal, which is
similar to the earlier results from the PA monolayers with 20
wt % SP-B1-25. Table 4 shows the average tilt angles of the
peptides between 15 and 20 ns in the simulations with one
peptide. When the initial tilt angles of the peptides are
between 0 and 65, the ﬁnal tilt angles end up between 33
and 65. On the other hand, initially horizontally oriented
peptides have average ﬁnal tilt angles of 86 ; 96. This
behavior is similar to that of systems with 20 wt % SP-B1-25,
suggesting that changes in concentration up to 20 wt % SP-
B1-25 do not signiﬁcantly affect the tilt angle, at least over the
timescales of these simulations.
Hydrogen-bonding interaction between SP-B1-25
and PA monolayers
Although the PA tail region consists of uncharged hy-
drophobic hydrocarbon chains, the headgroup region of PA
has a negatively charged carboxyl group, which can form
hydrogen bonds with the peptides, particularly with the
cationic amino acids. These hydrogen bonds play an
important role in determining the ﬁnal conformation of the
peptide in the monolayers. Here, we investigate the spe-
ciﬁc effects that different amino acids, and their different
hydrogen-bonding patterns, have on the orientation and
conformation of the peptide. Although the peptide backbone
donors have the ability to form hydrogen bonds with the PA
TABLE 3 Average tilt angles of SP-B1-25 averaged over the time
period 20–30 ns for each of six molecules in each system
(column 2), and over all six molecules over this period
(column 3), for systems with different initial conditions
Range of tilt angle () Average tilt angle ()
SPB1 48 ; 81 65
SPB2 37 ; 77 62
SPB3 39 ; 70 54
SPB4 42 ; 86 60
SPB5 34 ; 82 67
SPB6 48 ; 124 78
SPB7 73 ; 112 91
SPB8 29 ; 72 41
Experiment (32) 56
FIGURE 6 Tilt angles of the peptides in the PA monolayers having
one peptide with initially (a) vertical, (b) 50-tilted, and (c) horizontal
orientation, 90. The peptides with initially vertical conﬁguration tend to tilt
toward the monolayer, whereas the peptides with initially horizontal
orientation remain horizontal.
MD Simulation of Lung-Surfactant Peptide 3815
Biophysical Journal 89(6) 3807–3821
headgroups, these hydrogen bonds are less signiﬁcant than
those of the side chains, because most peptide backbone
donors are used up in forming the helical backbone structure
and also are less accessible to the PA than are the side chains
(34). Therefore, we only analyze the hydrogen-bonding
characteristics of the side chains of the SP-B1-25 peptide. The
amino acids of SP-B1-25 that have side chains with hydrogen-
bonding capabilities are tyrosine 7 (Y-7), tryptophan 9 (W-
9), arginine 12 (R-12), lysine 16 (K-16), arginine 17 (R-17),
glutamine 19 (Q-19), and lysine 24 (K-24). Tyrosine has one
donor and one acceptor, the latter being an uncharged, but
polar, hydroxyl group, and glutamine has two donors and
one acceptor, the latter being an uncharged, but polar, side
chain. Arginine and lysine have ﬁve and three donors,
respectively, due to their charged side chains, which can
make hydrogen bond interactions with the anionic head-
groups of ionized PA molecules. Tryptophan has one donor
with an indole ring joined to a methylene group, which
makes tryptophan highly hydrophobic. These donors and
acceptors were analyzed to determine the number and
duration of hydrogen-bonding interactions, which play an
important role in determining the conformation of the pep-
tide in the monolayer.
We base the criterion for the existence of hydrogen bonds
on the distance between the donor and the acceptor, and the
angle formed by the donor, the acceptor, and the hydrogen.
Speciﬁcally, we assume that a hydrogen-bonding interaction
exists when the hydrogen-acceptor distance is,0.25 nm and
the angle of the donor-hydrogen-acceptor triplet is .120
(46). Analyses were performed using different distance and
angle criterions, including 0.2 nm-150 and 0.25 nm-150,
which showed that these stricter criteria produce similar
qualitative trends (34). Therefore, the 0.25 nm-120 criterion
was used for our hydrogen-bonding analysis of all the
simulations.
Fig. 7, a and b, shows hydrogen bond existence maps for
Y-7 and K-16 in simulation SPB2 with 25%-ionized PA. Fig.
7 a shows the hydrogen bond existence map of Y-7, which
has one donor and one acceptor that can make hydrogen
bonds with acceptors or donors of the headgroups in PA
molecules. The scheme in Fig. 7 a shows that, during the
course of the simulation, Y-7 makes 14 unique hydrogen
bonds (numbers of unique acceptor-donor sites in hydrogen
bond map) with ionized or un-ionized PA molecules, which
are in the vicinity of the peptide. Note that the side chains of
the peptide will not be able to interact with distant PA
molecules because of the low diffusivity of the PA molecules
and the short simulation timescale. Since Y-7 was initially
located in the hydrophobic tail region of the monolayer,
hydrogen bonds between the peptide and PA are unlikely to
occur at the beginning of the simulation. After 20 ns of
simulation, one persistent hydrogen bond (the 13th row of
unique acceptor-donor sites in the map) forms, showing that
an acceptor of Y-7 makes a strong hydrogen bond with
a donor of one un-ionized PA. This trend is also observed in
Q-19, which has two donors and one acceptor. Q-19 was
initially positioned in the water phase and forms hydrogen
bonds with the PA molecules after ;9 ns. The acceptor of
Q-19 forms an interaction with the donor of a un-ionized PA
molecule, and a donor of Q-19 forms an interaction with an
acceptor of either an ionized or a un-ionized PA. Therefore,
both Y-7 and Q-19 have interactions with donors or ac-
ceptors of PA, suggesting that they can interact with both
un-ionized and ionized PA.
Fig. 7 b shows that the three cationic donors of K-16 can
form three hydrogen bonds with the anionic headgroups of
ionized PA molecules. In K-16, frequent breaking and
reforming of the same set of three hydrogen bonds is
observed apparently because the three hydrogen atoms of the
amine group in lysine compete for the same acceptor,
causing symmetric rotation around the acceptor of the closest
PA. In K-24, a similar rotation among three hydrogen bonds
is observed again due to the symmetrical rotation of three
hydrogens. However, in simulation SPB-1, there are no
persistent interactions between K-16, K-24, and the 0%-
ionized PA monolayer, suggesting that lysine preferentially
interacts with ionized PA molecules. These trends are also
observed in R-12 and R-17. The ﬁve cationic donors of R-12
can form ﬁve persistent hydrogen bonds with the anionic
headgroups of ionized-PA molecules, whereas R-12 does not
form hydrogen bonds with 0%-ionized PA monolayer
(simulation SPB1). R-12 forms ﬁve persistent hydrogen
bonds, whereas R-17 forms only two persistent hydrogen
bonds with ionized PA molecules, apparently because R-17
is not in the PA headgroup region, and thus there are fewer
ionized PA molecules around R-17. W-9 does not form
interactions with either ionized or un-ionized PA because
tryptophan has a bulky side chain, which can block the
hydrogen-bonding site. These hydrogen bond studies
conﬁrm the inference of Freites et al. (35) from short MD
simulations that the cationic residues of SP-B1-25 help anchor
the peptide to the PA monolayer.
The effect of hydrogen-bonding interaction
on the conformation of SP-B1-25
Fig. 8, a and b, shows the total number of hydrogen bonds
for each peptide in simulations SPB2 and SPB7. In
simulation SPB2, all peptides are initially oriented vertically,
and the ﬁnal average tilt angle is;62. On the other hand, in
simulation SPB7, all the peptides are initially oriented
TABLE 4 Tilt angles of peptides in PA monolayers having
one SP-B1-25
Initial tilt angle Final tilt angle (15 ; 20 ns)
Lower layer Upper layer Lower layer Upper layer
0 0 65 33
65 47 54 58
73 83 86 96
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horizontally, and the ﬁnal average tilt angle is ;91. In Fig.
8 a, the numbers of hydrogen bonds increases slowly until 10
; 15 ns and eventually levels out, whereas in Fig. 8
b leveling out occurs earlier because in the latter, the initial
parallel peptide orientation allows hydrogen-bonding pairs
to be created more rapidly. Note that the ﬁnal number of
hydrogen bonds is similar for each orientation, suggesting
that an equilibrium number has been formed. This large
number of hydrogen bonds that form rapidly in the initially
parallel orientation apparently pins the peptide in this
orientation and therefore might be partially responsible for
the lack of change in the tilt angles of the peptides in SPB7.
We analyzed quantitatively the average lifetime of the
hydrogen bonds from the integral of the average over auto-
correlation functions of the hydrogen-bonding existence
functions (either 0 or 1) of all hydrogen bonds (36). Average
hydrogen bond lifetimes were measured over the last 10 ns of
the simulations of the peptides to understand the effect of
each amino acid on hydrogen bond lifetime. In our simu-
lations of SP-B1-25 in 25%-ionized PA monolayers, there are
a total of 48 peptides in eight monolayer systems with a wide
range of tilt angles. These peptides were categorized ac-
cording to their individual tilt angles averaged over the last
10 ns of the simulations, without regard to which simulations
(i.e., which initial conditions) they were drawn from. We
focused on three different ranges: 29; 39, 51; 57, and
81 ; 86. In each range of the tilt angle, 5 ; 8 peptides
were sampled from 4 ; 5 different simulations with 25%-
ionized PA monolayers.
Fig. 9 shows the average hydrogen bond lifetimes of each
amino acid in the sampled peptides. Arginine and lysine have
cationic side chains and form strong hydrogen bonds with
the anionic headgroups of ionized PA molecules. Therefore,
each residue of R-12 and R-17 has almost equally long
hydrogen bond lifetimes for any range of the tilt angles,
suggesting that those arginine residues play an important role
in anchoring the peptide in the monolayer. Whereas R-12
and R-17 have long hydrogen bond lifetimes, K-16 and K-24
have relatively shorter hydrogen bond lifetimes, apparently
because of frequent breaking and reformation of hydrogen
bonds, which was shown in Fig. 7 b. On the other hand, Fig.
9 shows that each residue of Y-7 and Q-19 has longer
hydrogen bond lifetimes when the peptide tilt angle is in the
ranges of 51 ; 57 and 81 ; 86 than for smaller tilt
angles. This apparently occurs because Y-7 and Q-19, when
in less tilted peptides (relative to the perpendicular orienta-
tion), are less accessible to the monolayer. Since anchoring
of the peptide to the monolayer occurs whether or not Y-7
and Q-19 have persistent hydrogen bonds, apparently these
residues are less critical to peptide anchoring than are the
arginines. However, Y-7 and Q-19 may play an important
role in controlling the ﬁnal orientation of the peptides, since
FIGURE 7 Hydrogen bond existence
maps for (a) tyrosine 7 with 25%-
ionized PA and (b) lysine 16 with 25%-
ionized PA.
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these residues can gain more persistent hydrogen bonds
when the peptide is more nearly parallel to the monolayer.
The effect of individual amino acids on the
conformation of mutated SP-B1-25
We performed simulations of three mutated peptides (SPB2-
MUT1–SPB2-MUT3). Table 5 shows the amino acid
sequences of the mutated peptides. In SPB2-MUT1, Y-7
and Q-19 are replaced by alanine to observe if they are
important for tilting the peptide, which was discussed in the
analysis of hydrogen bonds. In SPB2-MUT2, all the argi-
nines and lysines, R-12, K-16, R-17, and K-24, are replaced
by alanines to remove the charged residues that were ob-
served to be important for anchoring the peptide into the mono-
layer. In SPB2-MUT3, all the residues with hydrogen bond
donors in their side chain are replaced by alanines.
Fig. 10 shows the average position of the PA headgroup
carbons and the backbone carbons of R-12 residues for the
three peptides in each monolayer over the whole simulation.
Although the centers of mass of the Ca atoms of the R-12
residues in SPB2 and SPB2-MUT1 are positioned close to
the center of mass of the PA headgroup carbons, the centers
of mass of the Ca atoms of the A-12 residues in SPB2-MUT2
and SPB2-MUT3 are positioned more deeply inside the tail
region of the PA monolayer, showing that the peptides in
SPB2-MUT2 and SPB2-MUT3 are more deeply inserted
into the tail region of the PA monolayer when arginine at
position 12 is replaced by alanine. This result suggests that
the interactions between charged residues of the peptide and
the headgroups of PA play an important role in anchoring the
peptides in the PA monolayers, supporting the conclusions
we drew from the hydrogen-bonding analysis. Table 6 shows
the number of hydrogen bonds of all six mutated SP-B1-25
peptides averaged over the last 10 ns of the simulations.
From this, we see that the hydrogen bond interactions of the
charged residues are much more numerous than those of the
uncharged residues; i.e., SPB2-MUT2 and SPB2-MUT3
have fewer hydrogen bonds than do SPB2 and SPB2-MUT1.
These results show that charged residues of the peptide
dominate the hydrogen-bonding interactions between the
peptide and the PA headgroups, anchoring the peptides to the
headgroup of PA.
Tilt angles of the mutated peptides were analyzed to
understand the effects of Y-7 and Q-19 on the tilting of the
peptide and the inﬂuence of hydrogen bonding on the tilt.
Table 7 shows average tilt angles of the mutated peptides
averaged over the last 10 ns of the simulations. Note that the
average tilt angle of SPB2-MUT1 is 39, which is much less
than the average tilt angle of SPB2, which is 62, showing
FIGURE 8 Total number of hydrogen bonds formed between SP-B1-25
and PA in SPB2 as a function of time for (a) SPB2 (initially perpendicular
peptide) and (b) SPB7 (initially horizontal peptide). Each line represents an
individual peptide in the monolayer.
FIGURE 9 Average hydrogen bond lifetimes of each amino acid residue
in the peptides, categorized according to the range of tilt angles shown.
TABLE 5 Sequences of mutated SP-B1-25
Name Sequence
SPB2 FPIPL PYCWL CRALI KRIQA MIPKG
SPB2-MUT1 FPIPL PACWL CRALI KRIAA MIPKG
SPB2-MUT2 FPIPL PYCWL CAALI AAIQA MIPAG
SPB2-MUT3 FPIPL PACAL CAALI AAIAA MIPAG
In SPB2-MUT1, Y-7 and Q-19 are replaced with alanine. In SPB2-MUT2,
R-12, K-16, R-17, and K-24 are replaced with alanine. In SPB2-MUT3, all
the residues having hydrogen-bond are replaced with alanine.
3818 Lee et al.
Biophysical Journal 89(6) 3807–3821
that Y-7 and Q-19 do play an important role in tilting the
peptides in the monolayers, which conﬁrms the conclusion
drawn from the analysis of hydrogen bond lifetimes. Note
also that the tilt angles of SPB2-MUT1 encompass a broad
range of values, 16–81. The average tilt angles of the six
individual peptides in SPB2-MUT1 are 16, 17, 22, 35,
66, and 81. For the two peptides having higher tilt angles
of 66 and 81, the backbones of the alanine counterparts of
Y-7 have 0.8 and 1.04 hydrogen bonds, respectively, and the
backbones of the alanine counterparts of Q-19 have 0.8 and
0.9 hydrogen bonds, whereas in the four peptides with lower
tilt angles, these numbers of hydrogen bonds are lower,
ranging from 0.05 to 0.75 backbone hydrogen bonds in the
alanine counterparts to Y-7 and from 0 to 0.43 backbone
hydrogen bonds in the counterparts of Q-19. This difference
suggests that the hydrogen bond interactions between
backbones of the mutated peptides and PA are correlated
with the tilting of the mutated peptide. This effect on tilt
angle of hydrogen bonding of backbone atoms is more
pronounced in SPB2-MUT1 than in the unmutated peptide
because the bulky side chains of tyrosine and glutamine in
the latter are replaced by a much smaller side chain, alanine,
in the former, which makes the headgroup of PA more
accessible to the backbones of the SPB2-MUT1 peptide.
Table 6 shows that the alanine counterpart of the a-helical
Q-19 has more backbone hydrogen bonds in the mutated
peptide than does Q-19 in the unmutated peptide. Pre-
sumably, this occurs because the introduction of alanine in
place of Q-19 breaks the a-helical structure of the latter,
freeing up the backbone atoms that are involved in forming
the a-helix in Q-19 and allowing them to form hydrogen
bonds with PA headgroups in the alanine mutant. However,
when Y-7 is replaced by alanine, the number of backbone
hydrogen bonds does not increase as much as occurs when
Q-19 is replaced by alanine because Y-7 and the alanine
counterpart of Y-7 are both coil-forming peptides, which
makes the headgroup of PA accessible to the hydrogen-
bond-forming backbone atoms of both mutated and un-
mutated peptides. To sum up, although in the unmutated
peptide SPB2 the hydrogen bonds with side chains of Y-7
and Q-19 help orient the peptide parallel to the interface,
when these amino acids are replaced by alanines, which
cannot form side-chain hydrogen bonds, the peptide back-
bone becomes more accessible to hydrogen bonding with the
headgroup of the PA, and this can also help orient the peptide
parallel to the interface for some of the peptides. However,
the majority of the peptides (four out of six) fail to form these
backbone hydrogen bonds and remain oriented more nearly
FIGURE 10 The average distance between center of mass of the Ca atoms
of R-12 or A-12 residues and center of mass of PA headgroup carbons in
SPB2, SPB2-MUT1, SPB2-MUT2, and SPB2-MUT3. Center of mass of PA
headgroup carbons is ﬁxed at the point 0 in the y axis. When Ca atoms of the
12th residue migrate toward the tail region of the monolayer, the distance
between the Ca atoms of the 12th residue and PA headgroup carbons
becomes positive. Migration toward the water yields a negative distance.
TABLE 6 Average number of hydrogen bonds of mutated SP-B1-25 averaged over the time period 20–30 ns for all six molecules
in each system
Average number of hydrogen bonds
Backbones Side chains
Y-7 Q-19 9th ; 25th Y-7 W-9 R-12 K-16 R-17 Q-19 K-24
SPB2 0.4 0.0 8.7 0.5 0.3 2.7 1.3 1.3 1.1 1.3
SPB2-MUT1 0.5 0.4 10.3 - 0.1 2.9 1.1 2.2 - 1.1
SPB2-MUT2 0.4 0.4 11.1 1.1 0.1 - - - 1.3 -
SPB2-MUT3 0.5 0.4 12.9 - - - - - - -
The numbers of hydrogen bonds were categorized as either backbone donors and acceptors (columns 2, 3, and 4) or side-chain hydrogen bond donors
(columns 5–11). The residues are named based on the SPB2 structure; in the mutants, alanines replace some of these residues, as indicated in Table 5.
Backbone hydrogen bonds are divided into those involving Y-7 and Q-19 or their alanine counterparts in SPB2-MUT1 and SPB2-MUT3 (columns 2 and 3),
and the remaining residues (column 4), which form an a-helical structure.
TABLE 7 Average tilt angles of mutated SP-B1-25 averaged over
the time period 20 ns–30 ns for each of six molecules in each
system (column 2), and over all six molecules over this
period (column 3)
Range of tilt angle () Average tilt angle ()
SPB2 37 ; 77 62
SPB2-MUT1 16 ; 81 39
SPB2-MUT2 32 ; 83 58
SPB2-MUT3 32 ; 85 58
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perpendicularly to the interface. Thus, the side-chain hydro-
gen bonds in the unmutated Y-7 and Q-19 more reliably
anchor the peptide in a highly tilted orientation than do the
backbone hydrogen bonds in the alanine-containing mutants.
The effect of each amino acid residue of SP-B1-25 on
the conformation of the peptide in the PA monolayer can
provide atomic-scale insights into the electrostatic interac-
tions between the peptide and the PA monolayer. Although
pure anionic PG and PA, which are important for the ad-
sorption and respreading of DPPC, have relatively low collapse
pressures relative to DPPC, it was observed experimentally
that both SP-B and SP-B1-25 increase the collapse pressure of
the PA monolayer to nearly 70 mN/m, which can be main-
tained in the absence of the peptide only by a monolayer of
pure DPPC. Longo et al. (31) found that an uncharged mu-
tant of SP-B was not able to increase the collapse pressure of
the PA monolayer, suggesting that speciﬁc charge interac-
tion between the anionic PA and the cationic protein is im-
portant for the monolayer stabilization. In our simulations,
electrostatic interactions between PA and SP-B1-25 were
investigated by a hydrogen bond analysis, which shows that
the charge interactions between R-12 and R-17 with anionic
PA play an important role in anchoring the peptide into the
interface between the monolayer and water, and the inter-
actions between Y-7 and Q-19 with PA are critical to control
the tilt of the peptide in the monolayer. The simulations
showing the anchoring effect of arginine residues thus com-
plement the experimental results by indicating which resi-
dues control peptide tilting.
CONCLUSIONS
MD simulations of 20 wt % LS peptide fragment SP-B1-25 in
PA monolayers were performed for 30 ns under various
conditions to understand the interactions between the peptide
and the monolayer and to test the ability of simulations to
predict experimentally measured peptide-monolayer proper-
ties. We varied the surface area of the PA, the extent of PA
ionization, and initial conﬁgurations of the peptides. We
found that the PA monolayer is partially disordered by the
presence of the peptide in that PA molecules both adjacent
and (to a lesser extent) nonadjacent to the peptides suffer
a reduction in tail order parameters, and the headgroup
region of the peptide is broadened, as some PAmolecules are
pulled out of the monolayer through interactions with
peptides. These results are consistent with the experimentally
observed peptide-induced ﬂuidization of the PA monolayer.
Peptides initially oriented perpendicular to a 25%-ionized
PA monolayer tilt to an angle averaging 54 ; 62 with
respect to the monolayer normal, which is similar to ex-
perimental results from x-ray reﬂectivity (32). In addition,
atomic-scale interactions between the peptide and monolayer
were analyzed by hydrogen-bonding analysis of unmutated
and mutated peptides, which showed that R-12 and R-17
help anchor the peptide to the monolayer by interacting
preferentially with the ionized PA molecules. Y-7 and Q-19
help control the tilt of the peptides in the monolayer through
interactions with the PA headgroup.
Although these simulations are able to complement the
experimental studies, the small system size and short
simulation timescale still limit the extent to which the ex-
perimental system can be adequately represented. In parti-
cular, it was observed that the formation of strong hydrogen
bonds prevents the system from overcoming local minima,
which makes it difﬁcult for the equilibrium ensemble to be
sampled adequately. In the future, longer runs on larger
systems should be attempted, and advanced methods, such as
replica exchange MD simulation and coarse-grained MD
simulations, should be used to improve sampling.
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